Search results for "Systemic"

showing 10 items of 757 documents

Dental considerations for the patient with renal disease

2011

Chronic renal disease (CRD) is the renal disease that manifests oral consequences most frequently, and it is defined as a progressive and irreversible decline in renal function associated with a reduced glomerular filtration rate (GFR). The most frequent causes of CRD are diabetes mellitus, arterial hypertension and glomerulonephritis. CRD is classified in 5 stages – from kidney damage with normal or increased GFR to renal failure. In order to quantify the CRD, renal function is measured using the GFR, which is estimated using creatinine clearance (CC). This CC is used for dose adjustment of drugs. In dental practice, the function of the kidneys can be measured indirectly through plasmatic …

medicine.medical_specialtySystemic diseaseAnemiamedicine.medical_treatmentRenal functionDrug intoleranceOdontologíaurologic and male genital diseasesGastroenterologychemistry.chemical_compoundInternal medicineDiabetes mellitusmedicineGeneral DentistryDialysisKidneyCreatininebusiness.industrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludeye diseasesSurgerymedicine.anatomical_structurechemistryUNESCO::CIENCIAS MÉDICASbusiness
researchProduct

Indications and contraindications of dental implants in medically compromised patients: update.

2013

The aim of this study was to review the current scientific literature in order to analyse the indications and contraindications of dental implants in medically compromised patients. A reference research was carried out on PubMed using the key words “implant” AND (oral OR dental) AND (systemic disease OR medically compromised), in articles published between 1993 and 2013. The inclusion criteria were the following: clinical studies in which, at least, 10 patients were treated, consensus articles, reviewed articles and meta-analysis performed in humans treated with dental implants, and which included the disease diagnosis. A total of 64 articles were found, from which 16 met the inclusion crit…

medicine.medical_specialtySystemic diseaseOsteoporosisMEDLINEOdontologíaDiseaseReviewRisk FactorsmedicineEndocrine systemHumansDiseaseGeneral DentistryContraindicationDental Implantsbusiness.industryContraindications:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseMedically compromised patients in DentistryCiencias de la saludSurgerystomatognathic diseasesOtorhinolaryngologyConcomitantUNESCO::CIENCIAS MÉDICASSurgeryImplantbusinessMedicina oral, patologia oral y cirugia bucal
researchProduct

Morbus Eales – 10 Jahre Erfahrung mit einem seltenen Krankheitsbild

2009

BACKGROUND: Eales’ disease is an uncommon vasoproliferative retinal disease affecting otherwise healthy young men. We report on our treatment results in a large patients group with long-term follow-up. PATIENTS AND METHODS: The treatment results in 50 eyes (35 patients) with Eales’ disease, that were cosecutively treated from May 1995 to August 2005, were analysed retrospectively. Recorded data included age, sex, race, association of systemic disease, medications, laboratory evaluation and the surgical treatment. Mean follow-up was 5.8 years (minimum: 3.2, maximum: 8.6 years). RESULTS: Systemic and laboratory evaluations detected a factor V Leiden mutation (4 × ), vestibuloauditory problems…

medicine.medical_specialtySystemic diseaseVisual acuitygenetic structuresbusiness.industrymedicine.medical_treatmentVitrectomyRetinalmedicine.diseaseeye diseasesSurgeryOphthalmologychemistry.chemical_compoundchemistryEales diseasemedicineCoagulopathyFactor V Leidenmedicine.symptomVasculitisbusinessKlinische Monatsblätter für Augenheilkunde
researchProduct

La guarigione della ferita chirurgica nel cavo orale

2021

OBJECTIVES The aim of the study is to describe the physiological mechanism of healing of the surgical wound of the oral cavity and to present the systemic and local factors that can influence it. MATERIALS AND METHODS Hemostasis starts with the activation of the platelets and the coagulation cascade which carry out the vascular constriction and the formation of the fibrin clot which stops the blood loss and provides a temporary scaffold for the migration and anchoring of the cells that will reach the subsequent stages. The clot and surrounding injured tissue begin to release pro-inflammatory cytokines and growth factors such as tranforming growth factor-β (TGF-β), platelet-derived growth fa…

medicine.medical_specialtySystemic factorsbusiness.industryLocal factorOrthodonticsSurgical woundOral cavityLocal factorOral cavitySurgeryHealing processMedicineSurgical woundOral SurgerybusinessDental Cadmos
researchProduct

AB0427 Clinical and laboratory findings in patients with late-onset sle and correlations with il6 concentrations

2013

Background Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease that usually develops in women aged 18-50 years. It is known that age at onset modifies the clinical manifestations of SLE, and so the elderly may form a specific patient subgroup. It is now well established that the serum levels of the cytokines interleukin (IL) 6 and IL10 are increased in patients with SLE (1). Objectives The primary aim was to compare the type of clinical involvement and autoantibodies in patients with late-onset (LO) or early-onset (EO) SLE. The second aim was to compare IL6 levels in the two patient groups and their possible correlations with clinical and immunological manifestations. Meth…

medicine.medical_specialtySystemic lupus erythematosusAnti-nuclear antibodybusiness.industryImmunologyAutoantibodyArthritismedicine.diseaseGastroenterologyGeneral Biochemistry Genetics and Molecular BiologyRheumatologyRheumatologyimmune system diseasesInternal medicineImmunologymedicineImmunology and AllergyAge of onsetmedicine.symptomskin and connective tissue diseasesMalar rashbusinessSerositisAnnals of the Rheumatic Diseases
researchProduct

Chronic Lupus Peritonitis Responsive to Treatment with Cyclophosphamide

1993

medicine.medical_specialtySystemic lupus erythematosusRheumatologyCyclophosphamidebusiness.industryInternal medicineMedicinePeritonitisPharmacology (medical)businessmedicine.diseaseGastroenterologymedicine.drugRheumatology
researchProduct

P172 Mainzer lupus score (MLS) a new questionnaire for lupus treatment

2020

Background For the diagnosis and treatment of the systemic lupus erythematosus (SLE), numerous scores and indices already exist with different focal points, which are mostly extensive and time consuming. The MLS is a short newly developed questionnaire consisting out of four items to consider whether it is necessary to adjust current therapy: Occurrence of new lupus-specific symptoms, subjective measurement of quality of life (Qol), change of serological abnormalities and the occurrence of organ damage accrual. Methods Patients who had at least 3 visits since 2016 in our clinic were able to participate. Spearman-correlation was used to correlate MLS and several other well established scores…

medicine.medical_specialtySystemic lupus erythematosusbusiness.industryDiseasemedicine.diseaseClinical routineOrgan damageDisease activityQuality of lifeInternal medicineActive diseaseMedicineskin and connective tissue diseasesbusinessDisease treatmentPoster presentations
researchProduct

P125 Internet-based exercise therapy in patients with systemic lupus erythematodes – systemic lupus erythematodes exercise program (SLEEP)

2020

Background The SLEEP study examines the effect of an exercise therapy against a control group with TAU therapy (Treatment as usual) in SLE to identify the effect of regular physical activity on muscular development. Furthermore, we investigate the effect of physical activity on disease activity and especially on fatigue syndrome. Molecular biological markers such as cfDNA and exosomes also detect the degree of the prostration of the patients. Methods Thirty SLE patients with laboratory as well as clinically stable status were included. The intervention group initially consisted of 24 patients, of which 12 were aerobically and 12 anaerobically active. In contrast, eight patients were include…

medicine.medical_specialtySystemic lupus erythematosusbusiness.industryPhysical fitnessPhysical exerciseInflammationCardiorespiratory fitnessmedicine.diseaseFibrosisInternal medicinemedicineProstrationSleep studymedicine.symptombusinessPoster presentations
researchProduct

Thrombotic thrombocytopenic purpura (TTP) leading to pseudotumour's autoimmune pancreatitis (AIP): A case report

2012

International audience; Introduction: Autoimmune pancreatitis is an idiopathic inflammatory disease that produces pancreatic masses and ductal strictures. This benign disease can be associated with extrapancreatic manifestations including cholangitis, sialadenitis, inflammatory bowel disease or retroperitoneal fibrosis, mediastinal adenopathy, interstitial nephritis mainly due to immunoglobulin G4 (Ig G4), and occasional association with other auto-immune diseases. Observation: We report a 57-year-old woman who developed thrombotic thrombocytopenic purpura (UP) and pseudo-tumour's seronegative autoimmune pancreatitis (ATP) type 1. The patient was initially treated with pulse corticosteroids…

medicine.medical_specialtyVON-WILLEBRAND-FACTOREndocrinology Diabetes and Metabolismmedicine.medical_treatmentInterstitial nephritisAnti-Inflammatory AgentsThrombotic thrombocytopenic purpuraRetroperitoneal fibrosisGastroenterologyInflammatory bowel diseaseDISEASEAutoimmune DiseasesAntibodies Monoclonal Murine-Derived03 medical and health sciences0302 clinical medicineThrombotic thrombocytopenic purpuraInternal medicine[SDV.IDA]Life Sciences [q-bio]/Food engineeringmedicineHumans[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringSYSTEMIC-LUPUS-ERYTHEMATOSUSAutoimmune pancreatitisAutoimmune pancreatitisPurpura Thrombotic ThrombocytopenicHepatologybusiness.industryENTITYGastroenterologyMiddle Agedmedicine.diseaseSialadenitis3. Good healthPancreatitis030220 oncology & carcinogenesisImmunologyFemale030211 gastroenterology & hepatologyRituximabPlasmapheresismedicine.symptombusinessRituximabmedicine.drug
researchProduct

P852Frequency and prognosis of type 2 myocardial infarction vs non ischemic myocardial injury: large observational study from an emergency department

2019

Abstract Background Type 2 Myocardial Infarction (T2MI), due to myocardial oxygen supply-demand mismatch in the absence of atherothrombosis and non-ischemic myocardial injury (NIMI), corresponding to troponin elevation without overt ischemia, are emerging concepts which are suspected to be common in patients hospitalized. However, their respective frequencies, risk profiles and short term prognosis in current routine clinical practice of emergency unit remains to be investigated. Methods Among the medical records of all the patients admitted from January 2014 to December 2016 in a university hospital emergency unit (n=82 543), patients with elevated troponin Ic (≥0.10μg/L) (n=4568) were sys…

medicine.medical_specialtybiologybusiness.industryC-reactive proteinIschemiaEmergency departmentmedicine.diseaseChest painTroponinSystemic inflammatory response syndromeInternal medicinemedicineCardiologybiology.proteinObservational studyMyocardial infarctionmedicine.symptomCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct